Skip to main content
Retour
GALNF logo

Galenica AG

Qualité des données : 100%
Suracheté
GALNF
OTC Healthcare Medical - Distribution
116,19 €
0,00 € (0,00%)
Cap. Boursière : 5,79B
Fourchette du Jour
75,25 € 116,19 €
Fourchette 52 Semaines
75,25 € 116,19 €
Volume
800
Moyenne 50J / 200J
116,19 € / 93,07 €
Clôture Précédente
116,19 €

Quick Summary

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (627 pairs)

Métrique Action Médiane du Secteur
P/E 32,0 0,3
P/B 3,9 3,0
ROE % 12,0 3,7
Net Margin % 4,4 3,8
Rev Growth 5Y % 1,9 10,0
D/E 0,7 0,2

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2030 5,31 €
5,19 € – 5,39 €
 5,12B 1
FY2029 4,83 €
4,71 € – 4,89 €
 4,88B 1
FY2028 4,52 €
4,41 € – 4,58 €
 4,70B 1

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-03-10 2,51 € 2,35 € -6,4%
2025-03-11 2,01 € 2,30 € +14,4%
2024-08-06 1,88 € 1,76 € -6,4%
2024-04-10 1,97 € 2,30 € +16,8%
2023-06-30 1,74 € 4,18 € +140,2%
2023-03-07 1,75 € 1,78 € +1,7%
2022-08-09 1,68 € 1,74 € +3,6%
2022-03-08 1,85 € 1,94 € +4,9%

Dividend History

Yield

0,03%

Payout Ratio

N/A

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

Points Clés

Revenue grew 1,92% annually over 5 years — modest growth
ROE of 11,95% — decent returns on equity
Generating 272,48M in free cash flow
P/E of 31,95 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3,60%
Cash machine — converts 150,39% of earnings into free cash flow

Croissance

Revenue Growth (5Y)
1,92%
Revenue (1Y)5,52%
Earnings (1Y)-0,96%
FCF Growth (3Y)35,08%

Qualité

Return on Equity
11,95%
ROIC6,57%
Net Margin4,38%
Op. Margin5,39%

Sécurité

Debt / Equity
0,72
Current Ratio1,15
Interest Coverage14,24

Valorisation

P/E Ratio
31,95
Forward P/EN/A
P/B Ratio3,90
EV/EBITDA30,22
Dividend Yield0,03%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 5,52% Revenue Growth (3Y) 5,10%
Earnings Growth (1Y) -0,96% Earnings Growth (3Y) 2,16%
Revenue Growth (5Y) 1,92% Earnings Growth (5Y) 1,96%
Profitability
Revenue (TTM) 4,14B Net Income (TTM) 181,19M
ROE 11,95% ROA 5,41%
Gross Margin 10,37% Operating Margin 5,39%
Net Margin 4,38% Free Cash Flow (TTM) 272,48M
ROIC 6,57% FCF Growth (3Y) 35,08%
Safety
Debt / Equity 0,72 Current Ratio 1,15
Interest Coverage 14,24
Dividends
Dividend Yield 0,03% Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 31,95 Forward P/E N/A
P/B Ratio 3,90 P/S Ratio 1,40
PEG Ratio -23,26 Forward PEG N/A
EV/EBITDA 30,22 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 4,71%
Market Cap 5,79B Enterprise Value 6,74B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 4,14B 3,92B 3,75B 4,01B 3,83B
Net Income 181,19M 182,95M 173,60M 165,13M 167,68M
EPS (Diluted) 3,63 3,67 5,72 3,32 3,38
Gross Profit 429,01M 1,09B 451,33M 374,13M 350,55M
Operating Income 222,88M 204,35M 191,29M 192,98M 186,33M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 3,35B 3,07B 2,99B 2,66B 2,62B
Total Liabilities 1,86B 1,52B 1,52B 1,41B 1,38B
Shareholders' Equity 1,48B 1,55B 1,47B 1,25B 1,23B
Total Debt 1,06B 235,89M 236,04M 686,49M 672,65M
Cash & Equivalents 115,56M 129,68M 116,16M 93,93M 164,98M
Current Assets 1,07B 1,03B 1,03B 976,72M 963,50M
Current Liabilities 933,39M 731,71M 772,27M 880,12M 664,90M

Scores de Stratégies

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#676 of 1052
38

Activité Récente

Entré Cash Flow Compounder
Mar 25, 2026